A comparative clinical study to evaluate the effect of kayaseka followed by daily purgation and immediate purgation in Rheumatoid arthritis
Phase 2
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
- Registration Number
- CTRI/2023/09/057283
- Lead Sponsor
- Priyanka Kalal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subjects aged between 18-60 years of both genders.
2.Subjects fulfilling the diagnostic criteria of Amavata.
3.Subjects indicated for Kayaseka and Virechana.
Exclusion Criteria
1.Subjects associated with uncontrolled Diabetes Mellitus, Hypertension, Cardiac diseases and other systemic disorders.
2.Rheumatoid arthritis patients with gross deformity.
3.Pregnant and lactating women.
• Patient with skin lesions, cuts, wounds
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in sandhi shotha,sandhi shoola,sandhi stabdathaTimepoint: • Before starting treatment – on 0th day <br/ ><br>• After completion of the treatment – on 8th day <br/ ><br>• Follow up period - 24th day.
- Secondary Outcome Measures
Name Time Method Reduction in CRP titer,RA factor titer & EULAR ScoreTimepoint: • Before starting treatment – on 0th day <br/ ><br>• After completion of the treatment – on 8th day <br/ ><br>• Follow up period - 24th day.